Good times can make it easier for investors to confuse the pretenders with the long-term winners, particularly if those pretenders are willing to ratchet up the risk and leverage in their business model to reap easy profits. When times get tough though, it is the best models and management teams that rise to the top. With the banking sector still firmly in the midst of malaise,
U.S. Bancorp (NYSE:
USB) is making a case that it may be the best bank investors can buy.
IN PICTURES: 9 Simple Investing Ratios You Need To Know
The Quarter That Was
Two significant points jump out with U.S. Bancorp's third quarter release - first, the company actually beat the
consensus revenue estimate, and it did not need to release any reserves to meet or beat its earnings target.
Revenue rose 1.5% on a sequential basis, helped by a 3% sequential increase in
net interest income. Unlike many banks, USB showed an increase in net interest margin (tiny as it may have been), and loans actually grew on a sequential basis. Total non-interest income was flat on a sequential basis, but fees did rise 5% as the company was able to offset deposit fee declines prompted by new banking regulations.
Advertisement - Article continues below.
On the credit side, the picture continues to slowly improve. Net
charge-offs improved sequentially, as did the ratio of
non-performing assets. Better still, the company made only modest reserves for mortgage repurchases, and the company seems well-positioned relative to other large banks like
Citigroup (NYSE:
C) and
Bank of America (NYSE:
BAC) when it comes to this particular controversy. (For related reading, check out
What Drives A Bank Of America Recovery?)
The Road Ahead
With a relatively clean balance sheet and a strong fee-generating business outside of deposit fees, U.S. Bancorp looks like it is in good shape for the future. On the other hand, while the company does appear to have a growing loan portfolio (relatively rare in this market), the company is paying up for deposits, with relatively high CD rates relative to
Wells Fargo (NYSE:
WFC),
Zions (Nasdaq:
ZION),
TCF (NYSE:
TCB) and so on. If the company can profitably (and safely) put this money to work, it can capture deposit marketshare that may be hard for banks to regain later. What's more, even if the company is willing to pay for
CDs, the overall cost of funding is still quite competitive.
U.S. Bancorp is in an enviable position on multiple fronts. This bank can probably hike its dividend more (and faster) than any other major bank, and the odds that there is still a ticking credit time-bomb in the balance sheet are low. If there is a problem with USB, it may be that its options to outperform are shrinking on a relative basis. The company did not fall as far as Bank of America or Citigroup (to name two examples), and does not have the same rebound opportunity. Also, the company's growth initiatives will take time to bear fruit and USB is limited in some respects - the company is too large to just buy into areas where it does not currently operate (like the South/Southeast regions). (For more, see
The Evolution Of Banking.)
The Bottom Line
U.S. Bancorp was not a profligate mortgage lender, nor a rapacious collector of deposit fees. That suggests that the company has less restructuring to do to compete in the new banking world, and that the company's historical ROE may be more attainable than for other banks. Investors who think USB can post long-term
ROE in the 16% range can probably expect solid long-term returns from this stock. (For related reading, check out
An Improving Tale For This Citi.)
Use the
Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis,
risk free!
by
Stephen D. Simpson, CFA, is a freelance financial writer, investor, and consultant. He has worked as an equity analyst for both sell-side and buy-side investment companies in both equities and fixed income. Stephen's consulting work has focused primarily upon the healthcare sector, while he has also written extensively for publication on topics pertaining to investments, security analysis, and healthcare. Simpson operates the
Kratisto Investing blog, and can be reached there.